Aletha Tarn is an associate in the Seattle office of Wilson Sonsini Goodrich & Rosati where her practice focuses on advising technology, life sciences, and emerging growth companies in corporate and securities law matters through all stages of growth.
During law school, Aletha interned at GE Healthcare and was a member of the Juelsgaard Intellectual Property and Innovation Clinic, where she helped draft amicus briefs to the Supreme Court and the Federal Circuit on behalf of pioneering computer scientists and legal innovation start-ups.
In addition to English, Aletha is fluent in German and proficient in Brazilian Portuguese, French, and Italian.
Aletha Tarn is an associate in the Seattle office of Wilson Sonsini Goodrich & Rosati where her practice focuses on advising technology, life sciences, and emerging growth companies in corporate and securities law matters through all stages of growth.
During law school, Aletha interned at GE Healthcare and was a member of the Juelsgaard Intellectual Property and Innovation Clinic, where she helped draft amicus briefs to the Supreme Court and the Federal Circuit on behalf of pioneering computer scientists and legal innovation start-ups.
In addition to English, Aletha is fluent in German and proficient in Brazilian Portuguese, French, and Italian.
Wilson Sonsini’s 2023 Technology and Life Sciences PIPE and RDO Report presents analysis related to 177 private investments in public equity (PIPEs) and registered direct offerings (RDOs) by U.S.-based technology and life sciences companies between January 1 and December 31, 2023. PIPEs and RDOs can be good alternatives to traditional underwritten offerings, particularly during periods of market volatility, because they can be negotiated discreetly and publicly announced after the parties agree to terms.